BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21951551)

  • 1. Clinical characteristics of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type β-lactamases.
    Qureshi ZA; Paterson DL; Peleg AY; Adams-Haduch JM; Shutt KA; Pakstis DL; Sordillo E; Polsky B; Sandkovsky G; Bhussar MK; Doi Y
    Clin Microbiol Infect; 2012 Sep; 18(9):887-93. PubMed ID: 21951551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum β-Lactamase-Producing Enterobacterales Bloodstream Infections?
    Hareza DA; Cosgrove SE; Simner PJ; Harris AD; Bergman Y; Conzemius R; Jacobs E; Beisken S; Tamma PD
    Clin Infect Dis; 2024 May; 78(5):1103-1110. PubMed ID: 37972276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: Results From the INCREMENT Cohort.
    Palacios-Baena ZR; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale P; Oliver A; Pintado V; Gasch O; Martínez-Martínez L; Pitout J; Akova M; Peña C; Molina Gil-Bermejo J; Hernández A; Venditti M; Prim N; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Giamarellou H; Almela M; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Paño-Pardo JR; Torre-Cisneros J; Souli M; Bonomo RA; Carmeli Y; Paterson DL; Pascual Á; Rodríguez-Baño J;
    Clin Infect Dis; 2017 Oct; 65(10):1615-1623. PubMed ID: 29020250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ertapenem Versus Meropenem for the Treatment of Extended Spectrum Beta-Lactamase-Producing Enterobacterales Bacteremia in Critically Ill Patients.
    VanDorf S; Shah P; Yost CN
    Ann Pharmacother; 2024 Jul; 58(7):690-697. PubMed ID: 37881901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease burden of bacteraemia with extended-spectrum beta-lactamase-producing and carbapenem-resistant Enterobacterales in Korea.
    Lee CM; Lee S; Kim ES; Kim HB; Park WB; Moon SM; Kim YK; Park KH; Kwak YG; Kim B; Kim YS; Kim CJ; Gil HY; Ahn J; Song KH
    J Hosp Infect; 2024 Feb; 144():85-93. PubMed ID: 38072088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Available evidence of antibiotic resistance from extended-spectrum β-lactamase-producing Enterobacteriaceae in paediatric patients in 20 countries: a systematic review and meta-analysis.
    Hu YJ; Ogyu A; Cowling BJ; Fukuda K; Pang HH
    Bull World Health Organ; 2019 Jul; 97(7):486-501B. PubMed ID: 31258218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, Senegal.
    Ndir A; Diop A; Ka R; Faye PM; Dia-Badiane NM; Ndoye B; Astagneau P
    Antimicrob Resist Infect Control; 2016; 5():13. PubMed ID: 27096085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Christiansen CH; Ravn C; Wang M
    Ugeskr Laeger; 2023 Jun; 185(24):. PubMed ID: 37325986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit.
    Papadimitriou-Olivgeris M; Marangos M; Christofidou M; Fligou F; Bartzavali C; Panteli ES; Vamvakopoulou S; Filos KS; Anastassiou ED
    Scand J Infect Dis; 2014 Sep; 46(9):642-8. PubMed ID: 25017796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic Patterns of Multidrug-Resistant
    Rahimzadeh G; Rezai MS; Farshidi F
    Adv Biomed Res; 2023; 12():56. PubMed ID: 37200758
    [No Abstract]   [Full Text] [Related]  

  • 11. Korean Guidelines for Use of Antibiotics for Intra-abdominal Infections in Adults.
    Yoon YK; Moon C; Kim J; Heo ST; Lee MS; Lee S; Kwon KT; Kim SW; ;
    Infect Chemother; 2022 Dec; 54(4):812-853. PubMed ID: 36596690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of carbapenem resistance on mortality in patients infected with
    Zhou R; Fang X; Zhang J; Zheng X; Shangguan S; Chen S; Shen Y; Liu Z; Li J; Zhang R; Shen J; Walsh TR; Wang Y
    BMJ Open; 2021 Dec; 11(12):e054971. PubMed ID: 34907071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Carbapenem Resistance and Mortality Among Adult, Hospitalized Patients With Serious Infections Due to
    Martin A; Fahrbach K; Zhao Q; Lodise T
    Open Forum Infect Dis; 2018 Jul; 5(7):ofy150. PubMed ID: 30046639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Antimicrobial Susceptibility Patterns of ESBL, AmpC and Carbapenemase-producing
    Ghotaslou R; Sadeghi MR; Akhi MT; Hasani A; Asgharzadeh M
    Iran J Pharm Res; 2018; 17(Suppl):79-88. PubMed ID: 29796032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study.
    Ko JH; Lee NR; Joo EJ; Moon SY; Choi JK; Park DA; Peck KR
    Eur J Clin Microbiol Infect Dis; 2018 Feb; 37(2):305-311. PubMed ID: 29177611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital.
    Namikawa H; Yamada K; Fujimoto H; Oinuma KI; Tochino Y; Takemoto Y; Kaneko Y; Shuto T; Kakeya H
    Intern Med; 2017; 56(14):1807-1815. PubMed ID: 28717075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant
    Liao Y; Hu GH; Xu YF; Che JP; Luo M; Zhang HM; Peng B; Yao XD; Zheng JH; Liu M
    Exp Ther Med; 2017 Mar; 13(3):1003-1010. PubMed ID: 28450933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a Novel IncHI2 Plasmid Carrying Tandem Copies of blaCTX-M-2 in a fosA6-Harboring Escherichia coli Sequence Type 410 Strain.
    Guo Q; Ding B; Jové T; Stoesser N; Cooper VS; Wang M; Doi Y
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6742-6747. PubMed ID: 27572405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Molecular Characteristics of Neonatal Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacteremia: A 12-Year Case-Control-Control Study of a Referral Center in Taiwan.
    Tsai MH; Lee IT; Chu SM; Lien R; Huang HR; Chiang MC; Fu RH; Hsu JF; Huang YC
    PLoS One; 2016; 11(8):e0159744. PubMed ID: 27505270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.
    Sakellariou C; Gürntke S; Steinmetz I; Kohler C; Pfeifer Y; Gastmeier P; Schwab F; Kola A; Deja M; Leistner R
    PLoS One; 2016; 11(7):e0158039. PubMed ID: 27442425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.